As the Supreme Court prepares to rule on whether Roundup's manufacturer can be sued over cancer claims, lawyers are contesting a $7.25 billion class-action settlement, labeling it a 'sweetheart deal' for Monsanto. This challenge could delay the settlement, which is crucial for many affected individuals, as the court's decision is expected by early July.

• 01Lawyers argue the $7.25 billion settlement does not adequately compensate cancer victims and offers excessive protection to Monsanto.
• 02A motion was filed to move the case from state to federal court, potentially impacting the settlement's approval.
• 03The Supreme Court's decision on Roundup's liability is anticipated by early July, adding uncertainty for potential claimants.
• 04Bayer, which acquired Monsanto in 2018, is seeking to limit future lawsuits through both the Supreme Court ruling and legislative measures.
• 05The Environmental Protection Agency has not classified Roundup as a cancer risk, complicating the legal landscape for plaintiffs.

The outcome of the Supreme Court ruling and the settlement will significantly affect individuals who claim to have been harmed by Roundup, potentially determining their ability to seek compensation.